SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (TSXV:SGMD) announced that it will hold an earnings conference call (see details below) to discuss its third quarter 2022 financial results, including details on organic growth for the quarter, deal flow, and acquisition status, on Tuesday, January 17, 2023 at 5:00 pm (Eastern Time) and will issue an earnings press release earlier that morning.
Conference call/Webcast Information:
Fiscal Third Quarter Earnings Call Dial In: +1 (800) 245-3047
Conference ID: SALONA
For more information please contact:
Luke Faulstick
Chief Executive Officer
Tel: 1 (800) 760-6826
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
| Last Trade: | C$0.13 |
| Daily Volume: | 0 |
| Market Cap: | C$7.480M |
November 25, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
